Electronic Health Record Tools for Bronchiolitis
Trial Summary
What is the purpose of this trial?
The goal of this experimental study is to learn whether different types of best practice advisories (BPAs) that direct clinicians to reference clinical guidelines embedded in the electronic health record (EHR) increase the delivery of evidence-based care in children presenting to the hospital with bronchiolitis. The main questions it aims to answer are: * Do BPAs improve clinicians' delivery of guideline-concordant care in bronchiolitis? * Do interruptive BPAs improve guideline-concordant care of bronchiolitis more than non-interruptive BPAs? Researchers will compare the treatment and outcomes of patients whose clinicians did not receive a BPA, to those whose clinicians received a non-interruptive BPA, to those whose clinicians received an interruptive BPA. Patients will continue to receive standard hospital care for bronchiolitis. Clinicians will: * retain access to an EHR-embedded clinical guideline for bronchiolitis care * be exposed to either no BPA, a non-interruptive BPA, or an interruptive BPA promoting the EHR-embedded clinical guideline (randomized per patient encounter)
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications. It seems that patients will continue to receive standard hospital care for bronchiolitis, so it's likely that any changes to medication would be part of that standard care.
What data supports the effectiveness of the treatment Leveraging Electronic Health Record Tools for bronchiolitis?
Electronic health records (EHRs) can improve the quality of patient care by providing detailed clinical information that helps monitor and enhance treatment practices. This approach has been used to improve evidence-based care in other conditions, suggesting potential benefits for bronchiolitis treatment as well.12345
Is the use of electronic health record tools generally safe for humans?
Research shows that electronic health record tools can help detect adverse events (unintended harm from medical care) more accurately and efficiently, which can improve patient safety. However, there are usability challenges, especially in pediatric settings, that can lead to medication errors, such as improper dosing, which might harm patients.678910
How does the electronic health record tool treatment for bronchiolitis differ from other treatments?
The electronic health record (EHR) tool for bronchiolitis is unique because it focuses on improving the quality of care through better data management and decision support, rather than directly treating the condition with medication. This approach uses technology to enhance the accuracy and completeness of patient information, which can lead to more informed and effective treatment decisions.12111213
Research Team
Benjamin Bodnar, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for children hospitalized with bronchiolitis. There are no specific inclusion or exclusion criteria provided, suggesting that the study may be broadly applicable to pediatric patients admitted with this condition.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients receive standard hospital care for bronchiolitis with exposure to different types of BPAs
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Leveraging Electronic Health Record Tools
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor